Investment
Features
FeesSafety
Academy
More
Pluang+

Compare IDEXX Laboratories, Inc. (IDXX) vs Carparts.Com Inc (PRTS) Price & Performance

IDEXX Laboratories, Inc.Trade
Carparts.Com IncTrade

Price performance (Past 24H)

Key statistics

IDEXX Laboratories, Inc. vs Carparts.Com Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Carparts.Com Inc trades at $8.64 (market cap $66.42M). The key difference: IDEXX Laboratories, Inc. is far larger — about 608.7× Carparts.Com Inc's market cap, and Carparts.Com Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Carparts.Com Inc for 45 Days on average.

IDXXPRTS
Market Cap
$40.43B$66.42M
Volume
692,16440,287
Sector
HealthConsumer Cyclical
52-Week High
$766.68$10.00
52-Week Low
$504.70$3.88
Typical Hold Time
46 Days45 Days
Enterprise Value
$41.32B$79.39M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

IDEXX Laboratories, Inc.

IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.

Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.

Carparts.Com Inc

CarParts.com (PRTS) trades at $8.59, down 1.21% today, with a bullish technical outlook supported by moving averages. The company shows improving earnings momentum with three consecutive quarterly beats, though it remains unprofitable with negative net margins. Revenue has declined from $676M in 2023 to $548M in 2025, but recent quarters suggest stabilization. Analyst sentiment is positive with 60% buy ratings, while technical indicators show neutral oscillators and key support at $8.

The stock presents a turnaround opportunity with improving quarterly performance and strong analyst support, but faces significant fundamental challenges including persistent losses, declining revenue, and negative cash flow from operations. Investors should weigh the bullish technical setup against the company's ongoing profitability struggles and competitive e-commerce landscape.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IDXX

No sentiment data available yet.

PRTS
0% Buy100% Sell
Avg holding period · 45 Days

Top news

Latest headlines on both assets

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX →

About Carparts.Com Inc

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Read more on PRTS →